Zobrazeno 1 - 10
of 10
pro vyhledávání: '"J. A. Chodakewitz"'
Autor:
Angela Ngai, J. Somani, J. M. Arduino, Nicholas A. Kartsonis, Genovefa A. Papanicolaou, Kieren A. Marr, Ray Y Hachem, J. A. Chodakewitz, Carole A. Sable, C. J. Lipka
Publikováno v:
Transplant Infectious Disease. 6:110-116
Background. Mild, transient alanine aminotransferase (ALT) elevations were seen in Phase I studies of caspofungin and cyclosporin A (CsA). Methods. We conducted a retrospective chart review at four sites to characterize the hepatic safety in patients
Publikováno v:
Transplant Infectious Disease. 4:25-30
Caspofungin acetate is the first member of the novel echinocandin class of antifungal drugs to be marketed in the United States. It has recently been approved for use in patients with invasive aspergillosis who are refractory to or intolerant of conv
Autor:
Thomas J. Walsh, Desmond Ryan, Thomas F. Patterson, R. S. Berman, J Maertens, Mark J. DiNubile, Ray Y Hachem, Alfred J. Saah, Issam I Raad, P. Saddier, David W. Denning, John W. Hiemenz, Carole A. Sable, J. A. Chodakewitz, M. E. Severino
Publikováno v:
European journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology. 29(11)
In a non-comparative study, caspofungin was effective salvage therapy for approximately half of the patients refractory to or intolerant of standard antifungal agents for invasive aspergillosis. To establish a frame of reference for these results, we
Publikováno v:
The Journal of Immunology. 144:2190-2196
CSF have a broad range of effects on differentiated cells outside the bone marrow. Site-specific elaboration of these factors may influence local immune reactions. Keratinocytes have been demonstrated to produce a number of immunoactive cytokines, in
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 4(1)
Caspofungin acetate is the first member of the novel echinocandin class of antifungal drugs to be marketed in the United States. It has recently been approved for use in patients with invasive aspergillosis who are refractory to or intolerant of conv
Autor:
S M, Hammer, K E, Squires, M D, Hughes, J M, Grimes, L M, Demeter, J S, Currier, J J, Eron, J E, Feinberg, H H, Balfour, L R, Deyton, J A, Chodakewitz, M A, Fischl
Publikováno v:
The New England journal of medicine. 337(11)
The efficacy and safety of adding a protease inhibitor to two nucleoside analogues to treat human immunodeficiency virus type 1 (HIV-1) infection are not clear. We compared treatment with the protease inhibitor indinavir in addition to zidovudine and
Autor:
Lori J. Gabryelski, H L Robbins, D Laird, Donald J. Graham, R T Steigbigel, Daniel J. Holder, J A Chodakewitz, Malathi Shivaprakash, O M Blahy, F. E. Massari, Jon H. Condra, Robert M. Danovich, T Yang, Elizabeth Roth, Quintero Julio C, A Rhodes, William A. Schleif, Emilio A. Emini, K E Squires, Deutsch Paul J, Randi Y. Leavitt, J W Mellors, Hedy Teppler
Indinavir (IDV) (also called CRIXIVAN, MK-639, or L-735,524) is a potent and selective inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease. During early clinical trials, in which patients initiated therapy with suboptimal dosages of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b7b97919b851dd2170bcead88bfc7e3
https://europepmc.org/articles/PMC190914/
https://europepmc.org/articles/PMC190914/
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 144(6)
CSF have a broad range of effects on differentiated cells outside the bone marrow. Site-specific elaboration of these factors may influence local immune reactions. Keratinocytes have been demonstrated to produce a number of immunoactive cytokines, in
Publikováno v:
The Journal of Immunology. 140:832-836
Keratinocytes have been demonstrated to produce a number of cytokines, including growth factors such as the CSF IL-3. Circulating blood monocytes and some elicited macrophages retain a significant proliferative potential in response to colony-stimula
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 140(3)
Keratinocytes have been demonstrated to produce a number of cytokines, including growth factors such as the CSF IL-3. Circulating blood monocytes and some elicited macrophages retain a significant proliferative potential in response to colony-stimula